Approvals/TGA/CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial

Approved

STANDARD

CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e297194d820f0397
Product Name: CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial
Artg Id: 227351
Artg Name: CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2015-07-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-02220-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02216-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e297194d820f0397

Type

Standard